Biogen: Allergan or Merck? Neither
August 03, 2016 at 12:23 PM EDT
Whether or not Biogen ( BIIB ) gets bought is the big question among healthcare investors today. The WSJ reported yesterday that Allergan ( AGN ) and Merck ( MRK ) were interested in buying the biotech giant and since then, analysts have weighed in with abandon. But some analysts are at odds over which companies would be the best fit with Biogen, and at least one has already speculated about a price tag.